Tonga vs Uruguay: Prevalence of current tobacco use, females
Prevalence of current tobacco use, females over time
- Tonga
- Uruguay
How they compare
Uruguay currently reports 16.6% against 16.3% in Tonga, a difference of 0.3%.
Across all 9 years both countries report, Uruguay has been ahead every year.
Tonga ranks 44th and Uruguay ranks 43rd of 166 countries.
Uruguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Tonga | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.8% | 26.5% | 12.8% | Uruguay |
| 2010s | 14.8% | 21.7% | 6.9% | Uruguay |
| 2020s | 16.0% | 17.3% | 1.3% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, females, Tonga or Uruguay?
- Uruguay, at 16.6% against 16.3% in Tonga as of 2024.
- What is the difference in prevalence of current tobacco use, females between Tonga and Uruguay?
- 0.3%, with Uruguay ahead.
- How many years of comparable data are there for Tonga and Uruguay?
- 9 years are reported by both, from 2000 to 2024.
- How do Tonga and Uruguay rank globally for prevalence of current tobacco use, females?
- Tonga ranks 44th and Uruguay ranks 43rd of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, females (% of female adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the female population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.